Three Rivers Pharmaceuticals
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
Kadmon Corporation
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
hepatitis C treatments
infectious disease treatments |
| gptkbp:foundedIn |
2000
|
| gptkbp:headquartersLocation |
gptkb:Pittsburgh,_Pennsylvania,_United_States
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
antiviral medications
|
| gptkbp:bfsParent |
gptkb:Infergen
gptkb:Three_Rivers_(discontinued) |
| gptkbp:bfsLayer |
8
|
| http://www.w3.org/2000/01/rdf-schema#label |
Three Rivers Pharmaceuticals
|